- Home
- HCI vs ORKA Comparison
HCI vs ORKA Comparison
Compare HCI & ORKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCI
- ORKA
- Stock Information
- Founded
- HCI 2006
- ORKA 2004
- Country
- HCI United States
- ORKA United States
- Employees
- HCI N/A
- ORKA N/A
- Industry
- HCI Property-Casualty Insurers
- ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- HCI Finance
- ORKA Health Care
- Exchange
- HCI Nasdaq
- ORKA Nasdaq
- Market Cap
- HCI 1.2B
- ORKA 1.0B
- IPO Year
- HCI N/A
- ORKA N/A
- Fundamental
- Price
- HCI $114.47
- ORKA $19.97
- Analyst Decision
- HCI Buy
- ORKA Strong Buy
- Analyst Count
- HCI 5
- ORKA 6
- Target Price
- HCI $140.00
- ORKA $43.60
- AVG Volume (30 Days)
- HCI 112.1K
- ORKA 394.7K
- Earning Date
- HCI 11-07-2024
- ORKA 02-15-2025
- Dividend Yield
- HCI 1.40%
- ORKA N/A
- EPS Growth
- HCI 163.93
- ORKA N/A
- EPS
- HCI 11.94
- ORKA N/A
- Revenue
- HCI $750,846,000.00
- ORKA N/A
- Revenue This Year
- HCI N/A
- ORKA N/A
- Revenue Next Year
- HCI $14.52
- ORKA N/A
- P/E Ratio
- HCI $9.58
- ORKA N/A
- Revenue Growth
- HCI 48.73
- ORKA N/A
- 52 Week Low
- HCI $81.35
- ORKA $17.64
- 52 Week High
- HCI $126.50
- ORKA $53.88
- Technical
- Relative Strength Index (RSI)
- HCI 49.20
- ORKA N/A
- Support Level
- HCI $112.81
- ORKA N/A
- Resistance Level
- HCI $119.73
- ORKA N/A
- Average True Range (ATR)
- HCI 4.23
- ORKA 0.00
- MACD
- HCI 0.12
- ORKA 0.00
- Stochastic Oscillator
- HCI 56.83
- ORKA 0.00
About HCI HCI Group Inc.
HCI Group Inc is engaged in the property and casualty insurance business through two Florida domiciled insurance companies, Homeowners Choice Property & Casualty Insurance Company (HCPCI) and TypTap Insurance Company (TypTap). Both HCPCI and TypTap are authorized to underwrite various homeowners' property and casualty insurance products and allied lines business in the state of Florida and other states. The operating segments of the group are HCPCI insurance operations, TypTap Group, Real estate operations, and Corporate and other. It derives key revenue from the HCPCI Insurance operation segment.
About ORKA Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics Inc is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. It is to offer patients suffering from chronic skin diseases like plaque psoriasis.